No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
81 |
4. Check minimum number of eventsNone |
81 |
5. Include endpointsNone |
81 |
6. Filter based on genotype QC (FinnGen only) |
81 |
Control definitions (FinnGen only)
- Control exclude
- E4_NUTRIDEF
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E50-E64
- Name in latin
- Sequelae malnutritionis et aliarum deficientiarum nutritionalium
Similar endpoints
↥List of similar endpoints to
Sequelae of malnutrition and other nutritional deficiencies
based on the number of shared cases.
Similar with more cases:
- Other nutritional deficiencies
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1025 | 566 | 443 |
| Only index persons | 738 | 414 | 324 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.02 | 0.01 |
| Only index persons | 0.01 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 73.60 | 76.42 | 70.18 |
| Only index persons | 72.79 | 75.38 | 69.48 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 81 | 37 | 44 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 67.48 | 59.65 | 74.07 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 75
- Matched controls
- 749
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E64.9
ICD-10 Finland
Sequelae of unspecified nutritional deficiency
+∞
75.1
59
*
D64.9
ICD-10 Finland
Anaemia, unspecified
11.8
17.8
37
57
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.0
6.9
34
128
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009445) Proteinase 3 Ab [Units/volume] in Serum
10
17
6.57
5.78
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
31
147
2.80
4.52
3.6
2.1
mg/l
3.0
2.8
0.18
25
127
(40760888) Immunoglobulin light chains.free panel - Serum
8
10
8.72
4.16
3.9
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
13
41
3.59
3.68
3.5
2.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
23
104
2.69
3.58
3.7
5.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
11
6.84
3.26
1.1
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
40
243
2.28
3.25
6.9
6.1
e9/l
0.0
0.0
0.41
33
214
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
16
64
2.87
3.10
4.5
3.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
36
215
2.21
2.99
5.4
3.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
13
5.78
2.93
2.9
2.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
6
8.77
2.78
3.2
1.7
pg
32.8
32.3
—
5
6
(3013115) Eosinophils [#/volume] in Blood
39
251
2.07
2.60
7.8
6.2
e9/l
0.1
0.2
0.27
34
223
(3019198) Lymphocytes [#/volume] in Blood
39
251
2.07
2.60
7.5
6.1
e9/l
1.5
1.7
1.11
34
228
(3001604) Monocytes [#/volume] in Blood
38
244
2.05
2.53
7.2
6.0
e9/l
0.5
0.6
2.17
33
214
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
24
129
2.22
2.52
2.0
1.8
mg/l
1.3
1.7
0.34
19
110
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
12
5.30
2.45
1.2
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
29
173
2.05
2.32
6.8
4.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
28
169
2.00
2.15
5.5
3.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
10
5.25
2.10
2.6
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
35
230
1.92
2.10
5.5
2.4
ug/l
240.0
117.0
1.30
30
209
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
26
3.30
2.07
4.2
2.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
13
59
2.43
1.96
1.2
1.4
—
232.9
—
0
17
(3012501) Base excess in Blood by calculation
6
17
3.72
1.87
5.3
2.6
mmol/l
1.6
1.9
—
6
10
(3027315) Oxygen [Partial pressure] in Blood
6
17
3.72
1.87
5.3
2.6
kpa
6.8
8.4
—
6
17
(3013290) Carbon dioxide [Partial pressure] in Blood
6
17
3.72
1.87
5.3
2.6
kpa
5.3
4.9
—
6
17
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
29
185
1.88
1.87
4.7
3.3
ng/l
3653.9
1919.7
0.45
24
160
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
41
2.64
1.83
6.0
7.9
mmol/l
24.9
25.0
—
10
41
(3000991) Gas panel - Venous blood
11
48
2.49
1.79
12.9
11.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
25
154
1.90
1.78
4.8
3.9
estimate
0.0
0.0
—
9
53
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
7
25
2.96
1.69
7.4
3.7
mmol/l
1.9
2.3
—
7
20
(3018418) pH of Serum or Plasma
27
175
1.81
1.63
10.8
3.6
ph
7.4
7.4
—
10
38
(46235355) HIV 1 and 2 tests - Meaningful Use set
15
79
2.10
1.62
2.7
1.8
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
20
3.15
1.61
1.2
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
15
3.48
1.54
6.8
2.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
26
170
1.78
1.51
3.3
2.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
17
97
1.95
1.49
4.8
3.7
mmol/l
0.8
0.8
0.35
17
88
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
37
269
1.69
1.48
16.2
6.5
mmol/l
1.2
1.2
0.59
30
220
(3026008) Bacteria identified in Urine by Culture
28
190
1.72
1.43
4.4
3.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
30
211
1.67
1.33
4.8
4.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
24
2.62
1.33
3.0
2.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
18
2.89
1.30
1.2
1.2
—
—
—
0
0
(3015736) pH of Urine
30
215
1.63
1.23
4.3
3.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
10
50
2.14
1.22
5.3
4.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
21
138
1.70
1.18
5.7
3.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
40
2.11
1.16
2.0
3.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
21
139
1.69
1.15
9.9
6.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
26
183
1.62
1.13
9.3
5.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
12
67
1.93
1.12
1.4
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
7
32
2.30
1.11
3.6
2.7
e6/l
0.1
0.2
—
7
32
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
45
2.12
1.09
2.0
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
22
2.35
1.05
3.0
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
35
2.09
1.03
2.7
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
9
49
1.94
1.03
3.0
3.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
10
54
1.97
1.02
8.5
4.1
mmol/l
1.2
1.2
—
10
48
(3037467) Urinalysis macro (dipstick) panel - Urine
46
377
1.51
1.00
7.0
4.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
11
62
1.90
1.00
2.1
4.7
ug/l
10.5
76.0
—
6
53
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
29
0.00
1.00
0.0
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
13
78
1.79
0.98
1.8
2.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
20
137
1.61
0.96
2.1
1.7
nmol/l
1305.7
1209.3
0.09
15
107
(3021601) Nitrite [Presence] in Urine by Test strip
36
284
1.48
0.92
8.1
5.5
estimate
0.0
0.0
—
10
55
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
38
308
1.44
0.83
3.8
3.0
u/l
96.9
54.4
0.50
33
288
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
6
33
1.88
0.81
14.3
3.3
mmol/l
23.8
24.4
—
6
33
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
33
1.88
0.81
4.0
8.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
12
75
1.70
0.80
2.5
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
35
282
1.42
0.78
6.1
4.0
estimate
0.0
0.0
—
10
55
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
12
76
1.68
0.77
2.5
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
24
2.15
0.76
2.6
2.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
56
1.68
0.75
2.1
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
17
119
1.54
0.74
3.0
2.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
57
1.65
0.74
1.2
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
15
102
1.58
0.74
1.6
1.3
g/l
2.6
2.5
—
6
52
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
30
240
1.40
0.68
4.9
4.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
35
289
1.37
0.65
6.2
4.0
estimate
0.0
0.0
—
9
52
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
54
1.53
0.59
1.6
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
28
227
1.36
0.58
2.7
2.1
pmol/l
89.8
89.3
0.02
19
115
(3013512) EKG study
20
153
1.41
0.57
4.2
5.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
30
246
1.35
0.57
17.6
7.4
inr
1.5
1.2
0.83
16
78
(3012544) pH of Venous blood
9
59
1.59
0.57
16.1
3.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
39
1.58
0.54
1.2
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
9
64
1.46
0.54
2.4
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
40
1.54
0.53
1.7
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
14
103
1.43
0.49
3.2
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
48
1.50
0.48
1.3
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
49
1.47
0.47
5.9
3.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
55
1.50
0.45
1.1
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
23
189
1.30
0.42
2.7
2.2
u/l
107.2
323.2
1.48
23
178
(3000494) Fungus identified in Specimen by Culture
8
59
1.39
0.42
1.9
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
37
326
1.25
0.39
9.0
5.3
mmol/l
7.2
6.8
0.43
37
305
(3044889) 12 lead EKG panel
40
356
1.24
0.39
5.1
4.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
16
127
1.32
0.37
2.0
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
45
492
0.81
0.37
4.2
4.8
mmol/l
6.2
6.0
0.18
36
433
(3019832) Treponema pallidum Ab [Presence] in Serum
6
43
1.43
0.36
1.0
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
44
477
0.83
0.30
4.1
4.5
mmol/l
1.5
1.5
0.19
38
425
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
45
484
0.84
0.27
5.5
4.6
mu/l
2.2
1.9
0.30
39
421
(3041096) Erythrocytes [Presence] in Urine by Automated
18
152
1.24
0.26
4.9
3.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
27
300
0.85
0.23
3.8
2.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
47
498
0.87
0.20
4.3
5.1
mmol/l
2.5
2.6
0.28
39
444
(3050129) First trimester maternal screen panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4035726)
6
52
1.17
0.19
1.2
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
68
1.20
0.17
2.4
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
14
161
0.84
0.17
5.9
4.6
%
26.7
21.3
—
5
89
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
49
514
0.88
0.16
38.8
17.1
mg/l
31.9
25.9
0.57
44
418
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
53
551
0.89
0.14
14.8
11.3
u/l
25.4
24.2
0.21
47
527
(40768804) Tissue Pathology biopsy report
20
218
0.89
0.12
2.1
2.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
45
469
0.91
0.11
37.6
16.4
ml/min/173m2
72.8
76.6
0.31
37
383
(1761868) Lipid panel - Serum or Plasma
13
145
0.88
0.10
2.8
3.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
65
1.08
0.08
13.7
9.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
16
147
1.11
0.08
3.9
3.1
mg/l
136.2
501.6
0.36
11
89
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
83
0.83
0.07
2.6
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
52
534
0.93
0.07
31.6
15.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
46
474
0.93
0.07
6.1
6.2
mmol/mol
41.1
41.0
0.02
37
438
(3013707) Erythrocyte sedimentation rate by Westergren method
40
391
1.05
0.03
5.3
4.0
mm/h
17.7
13.6
0.79
35
352
(3009542) Hematocrit [Volume Fraction] of Blood
46
459
1.01
0.00
40.6
18.4
%
36.5
38.7
0.67
27
303
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
6.4
—
0
7
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
6
63
0.95
0.00
1.0
1.3
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44790049)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
10.3
—
0
9
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806118)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4268621)
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790048)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
5.3
—
91.3
—
0
6
(44790047)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
8
0.00
0.00
0.0
3.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_SEQUMAL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_SEQUMAL | 2.544 [1.9, 3.41] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.426 |
During the follow-up period (1.1.1998 — 31.12.2019), 307 out of 483 females with E4_SEQUMAL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_SEQUMAL | 3.135 [2.06, 4.76] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.021 |
During the follow-up period (1.1.1998 — 31.12.2019), 255 out of 380 males with E4_SEQUMAL died.
Mortality risk
Mortality risk for people of age
years, who have E4_SEQUMAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.212% | 0.748% |
| 5 | 1.486% | 4.033% |
| 10 | 3.966% | 9.774% |
| 15 | 7.901% | 17.424% |
| 20 | 13.061% | 28.764% |
Relationships between endpoints
↥Index endpoint: E4_SEQUMAL – Sequelae of malnutrition and other nutritional deficiencies
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data